Deignan Charles A.

Officer at Clearside Biomedical, Inc.

Sold, on record
$115k
Dollars the filings state
Form 4 sales
7
Latest Jan 19, 2024
Form 144 notices
1
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Clearside Biomedical, Inc.Plan not stated
    Jun 7, 2016 2016

    Sold 2 shares at $7.00 ($14)

    Deignan Charles A., Chief Financial Officer

    Sold 0% of holdings ($439k position)62,759 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Clearside Biomedical, Inc.Plan not stated
    Jun 1, 2020 +1455 days

    Sold 14,992 shares at $1.88 ($28k)

    Deignan Charles A., Chief Financial Officer

    Sold 6.4% of holdings ($443k position)220,827 shares leftFirst sale on recordFiling

  3. 3 Form 4 sale Clearside Biomedical, Inc.Plan not stated
    Jun 21, 2021 +385 days

    Sold 2,938 shares at $4.37 ($13k)

    Deignan Charles A., Chief Financial Officer

    Sold 0.9% of holdings ($1.4M position)319,249 shares leftFiling

  4. 4 Form 4 sale Clearside Biomedical, Inc.Plan not stated
    Sep 21, 2021 +92 days

    Sold 2,800 shares at $6.41 ($18k)

    Deignan Charles A., Chief Financial Officer

    Sold 0.9% of holdings ($2M position)316,449 shares leftFiling

  5. 5 Form 4 sale Clearside Biomedical, Inc.Unusual
    Jan 19, 2022 +120 days

    Sold 8,833 shares at $2.09 ($18k)

    Deignan Charles A., Chief Financial Officer

    Sold 2.5% of holdings ($753k position)351,366 shares left3x usual sizeFiling

  6. 6 Form 4 sale Clearside Biomedical, Inc.Unusual
    Jan 19, 2023 +365 days

    Sold 14,030 shares at $1.50 ($21k)

    Deignan Charles A., Chief Financial Officer

    Sold 3.7% of holdings ($566k position)363,472 shares left4.8x usual sizeFiling

  7. 7 Form 144 notice Clearside Biomedical, Inc.Notice
    Jan 19, 2024 +365 days

    Filed to sell 12,900 shares ($17k)

    Deignan Charles A., Officer

    No 10b5-1 planFiling

  8. 8 Form 4 sale Clearside Biomedical, Inc.No plan
    Jan 19, 2024 same day

    Sold 12,900 shares at $1.28 ($17k)

    Deignan Charles A., Chief Financial Officer

    No 10b5-1 planSold 3.2% of holdings ($509k position)384,662 shares leftFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (8)

Form 144 notices and Form 4 sales by Deignan Charles A.
Source
Jan 19, 2024Jan 19, 2024Clearside Biomedical, Inc.Chief Financial OfficerForm 4 sale12,900$17k3.2%No planSEC
Jan 19, 2024Jan 19, 2024Clearside Biomedical, Inc.OfficerForm 144 notice12,900$17kNoticeSEC
Jan 19, 2023Jan 20, 2023Clearside Biomedical, Inc.Chief Financial OfficerForm 4 sale14,030$21k3.7%UnusualSEC
Jan 19, 2022Jan 20, 2022Clearside Biomedical, Inc.Chief Financial OfficerForm 4 sale8,833$18k2.5%UnusualSEC
Sep 21, 2021Sep 23, 2021Clearside Biomedical, Inc.Chief Financial OfficerForm 4 sale2,800$18k0.9%Plan not statedSEC
Jun 21, 2021Jun 23, 2021Clearside Biomedical, Inc.Chief Financial OfficerForm 4 sale2,938$13k0.9%Plan not statedSEC
Jun 1, 2020Jun 3, 2020Clearside Biomedical, Inc.Chief Financial OfficerForm 4 sale14,992$28k6.4%Plan not statedSEC
Jun 7, 2016Jun 7, 2016Clearside Biomedical, Inc.Chief Financial OfficerForm 4 sale2$140.0%Plan not statedSEC